Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Endometrial Physiology”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableUnknownNCT00173290
What this trial is testing

Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function

Who this might be right for
Cervical CancerBreast CancerEndometrial Cancer+1 more
National Taiwan University Hospital 200
Not applicableStudy completedNCT02150148
What this trial is testing

Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors

Who this might be right for
Cancer
University of Alabama at Birmingham 46
Not applicableStudy completedNCT01075386
What this trial is testing

The Effects of the Endocrine System on Endometrial Cancer

Who this might be right for
Endometrial Cancer
Queensland Centre for Gynaecological Cancer 75
Not applicableUnknownNCT04295109
What this trial is testing

Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function

Who this might be right for
Cervix NeoplasmsEndometrial CancerAdenomyosis+1 more
The First Affiliated Hospital with Nanjing Medical University 105
Not applicableEnded earlyNCT04939064
What this trial is testing

Endometrial Basis for Infertility in Women With Recurrent Implantation Failure and Pregnancy Loss

Who this might be right for
Normal Endometrial Physiology
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3
Early research (Phase 1)Not Yet RecruitingNCT06614751
What this trial is testing

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Who this might be right for
Solid CancersBRCA MutationHRD Cancer+8 more
Danatlas Pharmaceuticals Co., Ltd 112
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44